Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.

TitleEconomics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.
Publication TypeJournal Article
Year of Publication2010
AuthorsLee BY, Bailey RR, Wiringa AE, Afriyie A, Wateska AR, Smith KJ, Zimmerman RK
JournalVaccine
Volume28
Issue37
Pagination5952-9
Date Published2010 Aug 23
ISSN1873-2518
KeywordsComputer Simulation, Cost-Benefit Analysis, Decision Making, Disease Outbreaks, Humans, Influenza Vaccines, Influenza, Human, Models, Economic, Vaccination, Workplace
Abstract

Employers may be loath to fund vaccination programs without understanding the economic consequences. We developed a decision analytic computational simulation model including dynamic transmission elements that estimated the cost-benefit of employer-sponsored workplace vaccination from the employer's perspective. Implementing such programs was relatively inexpensive (<$35/vaccinated employee) and, in many cases, cost saving across diverse occupational groups in all seasonal influenza scenarios. Such programs were cost-saving for a 20% serologic attack rate pandemic scenario (range: -$15 to -$995) per vaccinated employee) and a 30% serologic attack rate pandemic scenario (range: -$39 to -$1,494 per vaccinated employee) across all age and major occupational groups.

DOI10.1016/j.vaccine.2010.07.003
Alternate JournalVaccine
PubMed ID20620168
PubMed Central IDPMC2926133
Grant List1P01HK000086-01 / HK / PHITPO CDC HHS / United States
1U54GM088491-0109 / GM / NIGMS NIH HHS / United States
5R01LM009132-02 / LM / NLM NIH HHS / United States
R01 LM009132 / LM / NLM NIH HHS / United States
R01 LM009132-02 / LM / NLM NIH HHS / United States
U54 GM088491 / GM / NIGMS NIH HHS / United States
U54 GM088491-01 / GM / NIGMS NIH HHS / United States
Publication Categories: